35
In band
Moving averages
SMA 200$1.79-57.06%
Company profile
iBio, Inc., a biotech company, provides contract development and manufacturing services to outside partners and customers in the United States. The company is headquartered in New York, New York.
SectorHealthcare
IndustryBiotechnology
Market cap$58.08M
P/E ratioNone
EPS$-0.32
Beta1.257
Dividend yield0.00%
52-week high$3.82
52-week low$0.77
Similar stocks in Biotechnology
BNTX
BioNTech SE
RSI 41
VRTX
Vertex Pharmaceuticals Inc
RSI 68
CRSP
CRISPR Therapeutics AG
RSI 48
IOVA
Iovance Biotherapeutics Inc
RSI 30
CRBU
Caribou Biosciences Inc
RSI 23
HRTX
Heron Therapeutics Inc
RSI 37
CGTX
Cognition Therapeutics Inc
RSI 32
BCTX
BriaCell Therapeutics Corp - New
RSI 31
IMUX
Immunic Inc
RSI 40
SAVA
Cassava Sciences Inc
RSI alerts for IBIO
An email when IBIO closes below RSI 30 or above 70. Nothing else.
Add alertData last updated 13 October 2026 at 9:47 PM EDT